Personalized Parameter Modeling with Synergistic Combinations

Publication ID: 24-11857765_0003_PTD
Published: November 07, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Personalized Parameter Modeling with Synergistic Combinations,” Published Technical Disclosure No. 24-11857765_0003_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857765_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,765.

Summary of the Inventive Concept

The invention integrates personalized parameter modeling with distinct technologies such as AI, IoT, blockchain, and new materials to create a more powerful and secure system for therapy management.

Background and Problem Solved

The original patent, 'Personalized parameter modeling methods and related devices and systems', provided a foundation for personalized therapy management. However, the system had limitations in terms of data security, predictive analytics, and integration with other technologies. The new inventive concept addresses these limitations by incorporating synergistic combinations of AI, IoT, blockchain, and new materials to enhance the system's capabilities and security.

Detailed Description of the Inventive Concept

The new system integrates a machine learning module with a sensing device to obtain current operational context information and historical operational context information. A blockchain-based secure data storage stores the historical operational context information and expected calibration factor models. An IoT-enabled infusion device receives calibrated measurement values and delivers fluid to the body of the patient. The system also incorporates AI-powered predictive analytics to determine expected calibration factor models and expected offset values. Additionally, the system utilizes new materials to enhance the sensing device's performance. The machine learning module updates the personalized parameter models based on new data, ensuring continuous improvement.

Novelty and Inventive Step

The new claims introduce the integration of AI, IoT, blockchain, and new materials with personalized parameter modeling, providing a novel and non-obvious solution. The inventive step lies in the synergistic combination of these technologies to create a more powerful and secure system for therapy management.

Alternative Embodiments and Variations

Alternative embodiments may include different machine learning algorithms, various IoT-enabled devices, or different blockchain-based data storage solutions. Variations may also include integrating the system with other technologies such as cloud computing or 5G networks.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the healthcare industry, particularly in the fields of diabetes management, personalized medicine, and therapy management. The system's enhanced capabilities and security features make it an attractive solution for patients, healthcare providers, and pharmaceutical companies.

CPC Classifications

SectionClassGroup
A A61 A61M5/1723
A A61 A61B5/14532
A A61 A61B5/4839
G G16 G16H10/60
G G16 G16H20/17
G G16 G16H40/40
G G16 G16H40/63
G G16 G16H50/20
G G16 G16H50/50
A A61 A61B5/0022
A A61 A61B5/02438
A A61 A61B5/7239
A A61 A61B5/7242
A A61 A61B2560/0242
A A61 A61B2562/0219
A A61 A61M5/14244
A A61 A61M2205/3569
A A61 A61M2205/502
A A61 A61M2205/52
A A61 A61M2205/70
A A61 A61M2230/005
A A61 A61M2230/06
A A61 A61M2230/201
G G16 G16H15/00

Original Patent Information

Patent NumberUS 11,857,765
TitlePersonalized parameter modeling methods and related devices and systems
Assignee(s)MEDTRONIC MINIMED, INC.